Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2012
05/31/2012US20120135997 Pharmaceutical composition comprising a lactam or benzenesulfonamide compound
05/31/2012US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta
05/31/2012US20120135990 Iap inhibitors
05/31/2012US20120135989 Azaindole derivative
05/31/2012US20120135987 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
05/31/2012US20120135986 Bicyclic Heteroaryl Compounds
05/31/2012US20120135982 5HT2c RECEPTOR MODULATORS
05/31/2012US20120135981 Novel substituted triazole and imidazole derivatives as gamma secretase modulators
05/31/2012US20120135975 Substituted Esters as Cannabinoid-1 Receptor Modulators
05/31/2012US20120135968 Tetracycline Compounds
05/31/2012US20120135885 Methods and Kits Using Extended Rhodamine Dyes
05/31/2012US20120134955 Pyrimidopyrimidoindazole derivative
05/31/2012CA2816395A1 Antifungal 5,6-dihydro-4h-pyrrolo[1,2-a] [1,4]- benzodiazepines and 6h-pyrrolo[1,2-a] [1,4]benzodiazepines substituted with phenyl derivatives
05/31/2012CA2815029A1 Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as jak inhibitors
05/30/2012EP2457914A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
05/30/2012EP2457913A2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith
05/30/2012EP2457911A1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nAChR ligands for the treatment of CNS diseases.
05/30/2012EP2457898A1 Fullerene derivative
05/30/2012EP2457896A1 Tripeptides as caspase modulators
05/30/2012EP2457895A1 Tetrapeptide analogs
05/30/2012EP2456763A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
05/30/2012EP2456757A2 Hdac inhibitors and therapeutic methods using the same
05/30/2012EP2456444A1 Certain chemical entities, compositions and methods
05/30/2012EP2456311A1 Substituted imidazotriazines
05/30/2012EP1670787B1 Cytokine inhibitors
05/30/2012CN202246493U Device for decoloring urotropin mother liquor by using gas phase method
05/30/2012CN102482505A 用于喷墨油墨的近红外吸收酞菁和萘酞菁 Near-infrared absorbing ink for ink-jet phthalocyanine and Naphthalocyanine
05/30/2012CN102482292A Modulators of 5-ht receptors and methods of use thereof
05/30/2012CN102482288A 由4种同分异构体的混合物组成的酞菁衍生物 A phthalocyanine derivative represented by four kinds of isomers of a mixture of the
05/30/2012CN102482287A 作为C-Met酪氨酸激酶调节剂的3-杂芳基甲基-咪唑并[1,2-B]哒嗪-6-基衍生物 As the C-Met tyrosine kinase modulators heteroaryl methyl 3 - imidazo [1,2-B] pyridazin-6-yl derivatives
05/30/2012CN102482286A Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
05/30/2012CN102482285A Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
05/30/2012CN102482284A 作为jak抑制剂的吡唑并嘧啶化合物和方法 As jak inhibitor pyrazolopyrimidines compounds and methods
05/30/2012CN102482283A Raf抑制剂化合物及其使用方法 Raf inhibitor compounds and methods of use
05/30/2012CN102482282A 多环化合物的新形式 New forms of polycyclic compounds
05/30/2012CN102482281A 吡咯并[2，3-d]嘧啶衍生物 Pyrrolo [2,3-d] pyrimidine derivatives
05/30/2012CN102482280A 作为雄激素受体的配体的[1，2，4]三唑并[4，3-b]哒嗪 As the androgen receptor ligand [1,2,4] triazolo [4,3-b] pyridazine
05/30/2012CN102482279A Organic electronic device, compounds for same, and terminal
05/30/2012CN102482276A 杂环化合物及其用途 Heterocyclic compounds and their use
05/30/2012CN102482262A 作为pde10a酶抑制剂的新的苯基咪唑衍生物 Phenyl-imidazole derivatives as a new inhibitor pde10a
05/30/2012CN102482258A α-螺旋模拟物和与其相关的方法 α- helix mimetics, and methods related thereto
05/30/2012CN102482228A 含有内酰胺或苯磺酰胺化合物的药物 Drug-containing lactam or benzenesulfonamide compound
05/30/2012CN102482227A 作为γ分泌酶调节剂的取代的三唑和咪唑衍生物 As the γ-secretase modulators substituted triazole and imidazole derivatives
05/30/2012CN102482203A 碳环glyt1受体拮抗剂 Carbocyclic glyt1 receptor antagonist
05/30/2012CN102477038A Novel lactim compound possessing cardiotonic action, its preparation method and its purpose
05/30/2012CN102477037A 多取代四氢合吡嗪[1,5-a]并咪唑-3（5H）酮类化合物的合成方法 Poly-substituted tetrahydro together pyrazine [1,5-a] and -3 synthesis method (5H) imidazole ketones
05/30/2012CN102030755B Method for preparing high-purity triethylene diamine
05/30/2012CN101974030B Preparation method of ammonium glyphosate technical product
05/30/2012CN101845046B Titanyl phthalocyanin crystal, method for preparing the same and electrophotographic photoconductor
05/30/2012CN101723947B Dipeptidase-IV inhibitor compound
05/30/2012CN101611014B Acylaminopyrazoles as FGFR inhibitors
05/30/2012CN101400657B Polycyclic cinnamide derivative
05/30/2012CN101360748B Inhibitors of c-met and uses thereof
05/30/2012CN101348754B Spirulina extract and preparation thereof
05/30/2012CN101313037B Diketopyrrolo-pyrrole compounds
05/29/2012US8188306 Heat shock protein 90 inhibitors
05/29/2012US8188272 Fused heterocyclic compounds useful as kinase modulators
05/29/2012US8188271 Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
05/29/2012US8188111 Amide and carbamate derivatives of alkyl substituted N-[4-(4-amino-1H-imidazo[4,5-c]quinolin-1-yl)butyI]methanesulfonamides and methods
05/29/2012US8188098 GPR119 receptor agonists
05/29/2012US8188097 Pyrazolo[1,5-A]pyrimidine compounds
05/29/2012US8188095 Gyrase inhibitors and uses thereof
05/29/2012US8188086 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
05/29/2012US8188068 Bridged polycyclic compound based compositions for coating oral surfaces in pets
05/29/2012CA2529561C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
05/29/2012CA2523196C Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
05/29/2012CA2483998C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
05/24/2012WO2012068450A1 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
05/24/2012WO2012068440A1 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
05/24/2012WO2012067822A1 Pyrazolo [1, 5 -a] pyrimidin potassium channel modulators
05/24/2012WO2012067425A1 Novel compound for organic electronic material and organic electroluminescent device using the same
05/24/2012WO2012067415A2 Compound and organic electronic device using same, and terminal comprising the organic electronic device
05/24/2012WO2012066061A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
05/24/2012WO2012065963A2 Novel antiviral compounds
05/24/2012US20120130097 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
05/24/2012US20120130087 Stereomerically Pure Fused Bicyclic Proline Compounds Useful for Preparing Hepatitis C Protease Inhibitors
05/24/2012US20120129873 Inhibitors of bruton's tyrosine kinase
05/24/2012US20120129865 Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
05/24/2012US20120129852 Azaindazoles as kinase inhibitors and use thereof
05/24/2012US20120129836 Imidazole derivatives as PDE10A enzyme inhibitors
05/24/2012US20120129833 Cyclic ketoenols for therapy
05/24/2012US20120128662 Substituted imidazoquinoxalines
05/24/2012US20120126214 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles
05/24/2012CA2818545A1 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
05/24/2012CA2818542A1 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
05/24/2012CA2818389A1 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
05/24/2012CA2817988A1 Benzodiazepine derivatives, compositions and methods for treating cognitive impairment
05/24/2012CA2817785A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
05/24/2012CA2817165A1 Novel antiviral compounds
05/23/2012EP2455382A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
05/23/2012EP2455380A1 Heterocyclic compound and use thereof
05/23/2012EP2455371A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
05/23/2012EP2454264A1 Tricyclic indole-derived spiro derivatives as crth2 modulators
05/23/2012EP2454263A1 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase
05/23/2012EP2454262A1 Pyrrolopyrazine inhibitors of kinases
05/23/2012EP2454261A1 Imidazo[1,2-alpha]pyrazin-3(7h)-one derivatives bearing a new electron-rich structure
05/23/2012EP2454260A1 Immunodetection and quantification of pyrazolopyrimidine sedatives
05/23/2012EP2454259A1 Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
05/23/2012EP2454258A1 Heterocyclic compounds as autotaxin inhibitors
05/23/2012EP2454253A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 573